BRCA1 and ovarian cancer: Further recontact regarding risk-reducing bilateral salpingo-oophorectomy (RRBSO) should occur at different ages depending on gene-specific ovarian cancer risk: 35–40 years (BRCA1) and 40–45 years (BRCA2).